Population Size, HIV, and Behavior Among MSM in Luanda, Angola: Challenges and Findings in the First Ever HIV and Syphilis Biological and Behavioral Survey
Supporting Files
-
Aug 15 2014
File Language:
English
Details
-
Alternative Title:J Acquir Immune Defic Syndr
-
Personal Author:
-
Description:Objectives
To conduct the first population size estimation and biological and behavioral surveillance survey among men who have sex with men (MSM) in Angola.
Design
Population size estimation with multiplier method and a cross-sectional study using respondent-driven sampling.
Setting
Luanda Province, Angola. Study was conducted in a large hospital.
Participants
Seven hundred ninety-two self-identified MSM accepted a unique object for population size estimation. Three hundred fifty-one MSM were recruited with respondent-driven sampling for biological and behavioral surveillance survey.
Methods
Interviews and testing for HIV and syphilis were conducted on-site. Analysis used Respondent-Driven Sampling Analysis Tool and STATA 11.0. Univariate, bivariate, and multivariate analyses examined factors associated with HIV and unprotected sex. Six imputation strategies were used for missing data for those refusing to test for HIV.
Main Outcome
A population size of 6236 MSM was estimated. Twenty-seven of 351 individuals were tested positive. Adjusted HIV prevalence was 3.7% (8.7% crude). With imputation, HIV seroprevalence was estimated between 3.8% [95% confidence interval (CI): 1.6 to 6.5] and 10.5% (95% CI: 5.6 to 15.3). Being older than 25 (odds ratio = 10.8, 95% CI: 3.5 to 32.8) and having suffered episodes of homophobia (odds ratio = 12.7, 95% CI: 3.2 to 49.6) significantly increased the chance of HIV seropositivity.
Conclusions
Risk behaviors are widely reported, but HIV seroprevalence is lower than expected. The difference between crude and adjusted values was mostly due to treatment of missing values in Respondent-Driven Sampling Analysis Tool. Solutions are proposed in this article. Although concerns were raised about feasibility and adverse outcomes for MSM, the study was successfully and rapidly completed with no adverse effects.
-
Subjects:
-
Source:J Acquir Immune Defic Syndr. 66(5):544-551.
-
DOI:
-
Pubmed ID:25014130
-
Pubmed Central ID:PMC4733005
-
Document Type:
-
Funding:
-
Name as Subject:
-
Place as Subject:
-
Volume:66
-
Issue:5
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ecb0b47bce9a9ef1efade05352c90519fafae489f91ac9a4acdfca0d8431a48940a3c0fefb14daed6c1eb7ea4b76b9b78ead0c034adb5bed1dcffc813dfef83d
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access